Addiction Drug Use Guidelines for Federal Workplace Drug Testing By Buddy T Buddy T Facebook Twitter Buddy T is an anonymous writer and founding member of the Online Al-Anon Outreach Committee with decades of experience writing about alcoholism. Learn about our editorial process Updated on March 26, 2021 Fact checked Verywell Mind content is rigorously reviewed by a team of qualified and experienced fact checkers. Fact checkers review articles for factual accuracy, relevance, and timeliness. We rely on the most current and reputable sources, which are cited in the text and listed at the bottom of each article. Content is fact checked after it has been edited and before publication. Learn more. by Emily Swaim Fact checked by Emily Swaim LinkedIn Emily is a board-certified science editor who has worked with top digital publishing brands like Voices for Biodiversity, Study.com, GoodTherapy, Vox, and Verywell. Learn about our editorial process Print SATURN STILLS / Getty Images Guidelines for drug testing of federal employees were first published by the U.S. Department of Health and Human Services (HHS) in 1988. The "Mandatory Guidelines for Federal Workplace Drug Testing Programs" have been revised several times since in 1994, 1997, 1998, 2004, 2008, and 2017. Developed by the Substance Abuse and Mental Health Services Administration (SAMHSA), the 50-page guidelines are aimed at standardizing drug testing policies and procedures for all federal employees in all federal agencies. Major Changes Proposed In 2004, SAMHSA proposed revisions to the guidelines. After public comment on the proposed changes, notice of the changes were published in November 2008 and went into effect in October 2010. Those proposals brought about several significant changes to government policy: Workplaces could do laboratory testing of hair, oral fluid, and sweat patch specimens in addition to urine specimens. Workplaces were allowed to test for the presence of marijuana, cocaine, phencyclidine, opiates (with a focus on morphine and heroin), and amphetamines [including methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA).] The guidelines allowed for the use of on-site, point-of-collection test (POCT) devices to test urine and oral fluid. Federal workplaces could use instrumented initial test facilities (IITFs) to quickly identify negative specimens. The guidelines established training requirements for collectors, on-site testers, and medical review officers (MROs). Those policies are still active, but the 2017 revisions put forth additional changes: Federal agencies could collect an alternate specimen (e.g. oral fluid) when a donor couldn't provide enough urine for a urine sample.Workplaces could test for additional substances, including oxycodone, oxymorphone, hydrocodone, and hydromorphone.The lower pH cutoff for identifying tampered urine samples with was raised from 3 to 4. (The minimum pH for unadulterated urine is roughly 4.5 pH.)The guidelines added requalification requirements for MROs. Certification of Laboratories Also, the guidelines establish the scientific and technical rules for federal workplace drug testing programs and establish standards for certification of laboratories engaged in drug testing for federal agencies. The revisions to the mandatory guidelines address the collection and testing of urine specimens, the requirements for certification of instrumented initial test facilities (IITFs), and the role of and standards for collectors and medical review officers (MROs). Defining the Requirements for Testing Specifically, the guidelines define the requirements for: Specimen collection proceduresCustody and control procedures that ensure donor specimen identity and integrityInitial and confirmatory test cutoff concentrations Analytical testing methodsResult review and reportingEvaluation of alternative medical explanations for positive testsLaboratory certification Combating Drug-Test Tricks The use of additional specimen testing, other than urine, came after a pilot program started in April 2000 to prepare performance testing materials for specimens other than urine to evaluate the labs' ability to achieve accuracy and precision. The addition of testing using hair, oral fluid, and sweat patch specimens to complement urine tests were proposed to combat industries devoted to "suborning urine drug testing through adulteration, substitution, and dilution," SAMSHA reported. The agency also reported that hair testing, which can detect drug use in the past 90 days using the first 1.5 inches of hair, could be useful in pre-employment testing. Oral fluid testing could detect drug use in post-accident situations, and sweat patch testing could be useful in connection with follow-up drug testing and treatment programs. Quick Results for Negative Tests The addition of the use of POCT devices and IITFs would give government agencies quick results in identifying negative specimens, while also indicating that the specimen is valid, SAMHSA noted. All federal agencies that conduct drug testing must follow the mandatory guidelines developed by SAMHSA, which includes having a medical review officer evaluate all test results and using a drug laboratory certified by the Department of Health and Human Services. Private Employers Use Guidelines Too Private employers who conduct drug testing of their employees are not required to follow SAMHSA's guidelines. However, adhering to the guidelines will help them stay on firm legal ground by using the federal procedures and by testing only for those drugs mentioned in the guidelines. According to SAMHSA, court decisions have supported following the guidelines. Consequently, many employers choose to follow the federal guidelines in developing their own drug testing programs. 4 Sources Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Substance abuse and Mental Health Services Administration. Mandatory guidelines for federal workplace drug testing programs. Fed Regist. 2008;73(228):71857-71907. Substance Abuse and Mental Health Services Administration. Mandatory guidelines for federal workplace drug testing programs. Fed Regist. 2017;82(13):7920-7970. Gryczynski J, Schwartz RP, Mitchell SG, O'Grady KE, Ondersma SJ. Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use. Drug Alcohol Depend. 2014;141:44-50. doi:10.1016/j.drugalcdep.2014.05.001 Substance Abuse and Mental Health Services Administration. Federal laws and regulations. By Buddy T Buddy T is an anonymous writer and founding member of the Online Al-Anon Outreach Committee with decades of experience writing about alcoholism. See Our Editorial Process Meet Our Review Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit Get Treatment for Addiction Advertiser Disclosure × The offers that appear in this table are from partnerships from which Verywell Mind receives compensation.